NEW YORK (GenomeWeb News) – MorphoSys' AbD Serotec unit today announced a research and supply agreement to provide the Dana-Farber Cancer Institute with its Slonomics technology.
Under the terms of the deal, research tools using the technology will be placed in the laboratory of Wayne Marasco at Dana-Farber. The Department of Cancer Immunology and AIDS at the institute is conducting research to develop transient immunity against life-threatening viral infections as part of a project funded by the Defense Advanced Research Projects Agency of the US Department of Defense.
MorphoSys acquired the Slonomics technology from Sloning Biotechnology in October for $26.5 million. Slonomics is a synthetic biology technology that enables the construction of protein libraries.
AbD Serotec has preferred access to the rights to commercialize products resulting from the agreement.
Other financial terms were not disclosed.